NYSE$CVS
CVS Health Corp · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
CVS Health reported Q3 2025 total revenues of $102.9B with net income attributable to CVS Health of $87M and diluted EPS of $0.07.
Total revenues were $102.9 billion for the quarter ended September 30, 2025, with net income attributable to CVS Health of $87 million and diluted EPS of $0.07. Results reflected pharmacy and health services mix, medical cost trends in Health Care Benefits, and prior-year comparability including large non-cash charges.
- Q3 total revenues $102.9B; net income attributable to CVS Health $87M.
- Diluted EPS $0.07 after prior-year loss comparability.
- Pharmacy and health services remain the core revenue engines.
- Medical cost and utilization trends continue to shape Health Care Benefits profitability.
Headline financials
Revenue & EPS history
CVS Health · Revenue · Quarterly
$103B
Revenue by segment
CVS Health · $102B total across 3 segments · Q3 2023
- Health Services$46.9B+8.5%45.9%
- Pharmacy & Consumer Wellness$28.9B+8.1%28.3%
- Health Care Benefits$26.3B+16.8%25.8%
Forward guidance
The release discusses CVS Health's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.
Tailwinds
- Management discussed operating priorities and capital allocation for upcoming quarters.
- CVS Health cites demand and execution supporting the near-term outlook.
- Liquidity and balance-sheet capacity support operations and shareholder returns.
Headwinds
- Macro, input costs, and FX may pressure margins quarter to quarter.
- Segment mix and one-time items can affect comparability versus prior periods.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.1%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+1.3%
Avg return
30 days after
56%
41 / 73 earnings
Positive
+14.9%
Q4 2024
Best reaction
-18.5%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.2% | +14.3% | +19.1% | |
| Q4 2025 | -0.1% | +3.6% | +0.4% | |
| Q3 2025 | -1.9% | -4.6% | -2.2% | |
| Q2 2025 | -0.3% | +1.8% | +17.4% | |
| Q1 2025 | +4.1% | -0.7% | -4.0% | |
| Q4 2024 | +14.9% | +19.7% | +19.4% | |
| Q3 2024 | +3.1% | +0.8% | -0.1% | |
| Q2 2024 | -0.8% | -4.3% | -1.0% | |
| Q1 2024 | -18.5% | -17.3% | -12.0% | |
| Q4 2023 | +1.8% | +4.8% | +1.8% | |
| Q3 2023 | +0.9% | +3.0% | -0.8% | |
| Q2 2023 | +0.5% | -0.1% | -11.2% | |
| Q1 2023 | -5.5% | -4.2% | -3.8% | |
| Q4 2022 | +4.8% | +4.5% | -10.3% | |
| Q3 2022 | +3.4% | +6.9% | +8.4% | |
| Q2 2022 | +6.8% | +7.0% | +4.3% | |
| Q1 2022 | +1.8% | +3.0% | -1.1% | |
| Q4 2021 | -5.0% | -7.1% | -6.6% | |
| Q3 2021 | +3.7% | +2.9% | -0.3% | |
| Q2 2021 | -4.7% | -2.8% | +4.1% | |
| Q1 2021 | +6.9% | +9.6% | +12.1% | |
| Q4 2020 | -2.0% | -5.1% | +0.4% | |
| Q3 2020 | +10.0% | +13.2% | +21.3% | |
| Q2 2020 | -1.3% | +1.1% | -7.3% | |
| Q1 2020 | +0.4% | +4.3% | +11.7% | |
| Q4 2019 | -2.5% | -3.4% | -19.2% | |
| Q3 2019 | +6.6% | +6.6% | +11.9% | |
| Q2 2019 | +9.2% | +8.6% | +15.0% | |
| Q1 2019 | +4.3% | +4.1% | -3.7% | |
| Q4 2018 | -10.8% | -12.4% | -19.8% | |
| Q3 2018 | +6.9% | +8.3% | +3.9% | |
| Q2 2018 | +4.8% | +6.2% | +18.1% | |
| Q1 2018 | -8.4% | -9.2% | -5.8% | |
| Q4 2017 | -6.7% | -5.7% | -6.8% | |
| Q3 2017 | -0.4% | +2.5% | +3.1% | |
| Q2 2017 | +0.4% | +0.4% | +1.6% | |
| Q1 2017 | -2.8% | -1.1% | -4.5% | |
| Q4 2016 | +1.9% | +2.1% | +4.4% | |
| Q3 2016 | -8.2% | -10.0% | -6.3% | |
| Q2 2016 | +4.2% | +4.2% | -0.1% | |
| Q1 2016 | +2.4% | — | — | |
| Q4 2015 | +3.9% | — | — | |
| Q3 2015 | -3.3% | — | — | |
| Q2 2015 | -1.4% | — | — | |
| Q1 2015 | +0.9% | — | — | |
| Q4 2014 | +3.0% | — | — | |
| Q3 2014 | +1.6% | — | — | |
| Q2 2014 | -0.4% | — | — | |
| Q1 2014 | +2.6% | — | — | |
| Q4 2013 | +2.4% | — | — | |
| Q3 2013 | +3.0% | — | — | |
| Q2 2013 | -4.1% | — | — | |
| Q1 2013 | +1.3% | — | — | |
| Q4 2012 | -1.0% | — | — | |
| Q3 2012 | +0.1% | — | — | |
| Q2 2012 | +1.5% | — | — | |
| Q1 2012 | +2.9% | — | — | |
| Q4 2011 | -1.2% | — | — | |
| Q3 2011 | +6.3% | — | — | |
| Q2 2011 | -5.7% | — | — | |
| Q1 2011 | +3.9% | — | — | |
| Q4 2010 | -0.2% | — | — | |
| Q4 2007 | -0.2% | — | — | |
| Q3 2010 | +3.2% | — | — | |
| Q2 2010 | -2.7% | — | — | |
| Q1 2009 | -2.8% | — | — | |
| Q1 2010 | -2.2% | — | — | |
| Q4 2009 | +1.2% | — | — | |
| Q3 2008 | -17.6% | — | — | |
| Q3 2009 | -17.6% | — | — | |
| Q4 2008 | +1.1% | — | — | |
| Q2 2008 | +1.1% | — | — | |
| Q2 2009 | +1.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro